Hantsbarger, G: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban : Results of a Multicenter, Placebo-Controlled, Randomized Trial

Kereiakes, D. J., Kleiman, N. S., Ferguson, J. J., Masud, A. R. Z., Broderick, T. M., Abbottsmith, C. W., Runyon, J. P., Anderson, L. C., Anders, R. J., Dreiling, R. J., Hantsbarger, G. L., Bryzinski,

Journal:

Year:

1998

Language:

english

File:

PDF, 521 KB

english, 1998

2

Milacemide: Safety assessment in senile dementia of the Alzheimer type

Maurice W. Dysken, T. Daniel Fakouhi, Stacy S. Skare, Joseph Mendels, Peter LeWitt, Hugh C. Hendrie, Thomas C. Venable, Gary L. Hantsbarger, Robert L. Herting

Journal:

Drug Development Research

Year:

1992

Language:

english

File:

PDF, 381 KB

english, 1992

3

Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: A Phase I/II Multicenter, Controlled, Multidose Study

Jeffrey S. Heier, Andrew N. Antoszyk, Peter Reed Pavan, Steven R. Leff, Philip J. Rosenfeld, Thomas A. Ciulla, Richard F. Dreyer, Ronald C. Gentile, Judy P. Sy, Gary Hantsbarger, Naveed Shams

Journal:

Year:

2006

Language:

english

File:

PDF, 311 KB

english, 2006

4

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Jeffrey S. Heier, Gary Hantsbarger, Naveed Shams

Journal:

Year:

2006

Language:

english

File:

PDF, 353 KB

english, 2006

5

931-113 Demonstration of Potent Inhibition of Platelet Aggregation with an Orally Active GPllb/IIIA Receptor Antagonist

Robert J. Anders, John C. Alexander, Gary L. Hantsbarger, Dan M. Burns, Stuart D. Oliver, Graham Cole, Desmond J. Fitzgerald

Journal:

Journal of the American College of Cardiology

Year:

1995

Language:

english

File:

PDF, 138 KB

english, 1995

6

686 Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects

N. Martin, R.A. Lewis, R. Vogel, N. Sheth, B. Sargent, D. Swearingen, S. Rasmussen, G. Hantsbarger, G.D. Novack

Journal:

European Urology Supplements

Year:

2012

Language:

english

File:

PDF, 68 KB

english, 2012

7

Randomized, Double-Masked, Placebo-Controlled Study to Assess the Ocular Safety of Mirabegron in Healthy Volunteers

Novack, Gary D., Lewis, Richard A., Vogel, Roger, Sheth, Neha, Swearingen, Dennis, Rasmussen, Scott, Hantsbarger, Gary, Martin, Nancy E.

Journal:

Journal of Ocular Pharmacology and Therapeutics

Year:

2013

Language:

english

File:

PDF, 210 KB

english, 2013

8

Nysius of South Dakota (Lygaeidae-Hemiptera)

William M. Hantsbarger

Journal:

Journal of the Kansas Entomological Society

Year:

1957

Language:

english

File:

PDF, 392 KB

english, 1957

9

Predaceous Mites of the Family Laelaptidae in North-Central Washington

Hantsbarger, W. M., O'Neill, W. J.

Journal:

Journal of Economic Entomology

Year:

1954

Language:

english

File:

PDF, 212 KB

english, 1954

10

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers

Rainsford, K D, James, C, Hunt, R H, Stetsko, P I, Rischke, J A, Karim, A, Nicholson, P A, Smith, M, Hantsbarger, G

Journal:

Clinical Pharmacology & Therapeutics

Year:

1992

Language:

english

File:

PDF, 414 KB

english, 1992

11

DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists

Cohen, R, Bhayat, F, Hantsbarger, G, Blake, A, Vermeire, S

Journal:

Journal of Crohn's and Colitis

Year:

2018

Language:

english

File:

PDF, 951 KB

english, 2018

12

Sa1699 - Safety of Vedolizumab in Patients Naïve to Treatment with TNF Antagonists Compared with Patients with Prior use of TNF Antagonists

Cohen, Russell D., Bhayat, Fatima, Hantsbarger, Gary, Blake, Aimee, Vermeire, Severine

Journal:

Gastroenterology

Year:

2018

Language:

english

File:

PDF, 649 KB

english, 2018

13

P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

Card, T, Ungaro, R, Bhayat, F, Blake, A, Hantsbarger, G, Travis, S

Journal:

Journal of Crohn's and Colitis

Year:

2019

Language:

english

File:

PDF, 1.38 MB

english, 2019

14

Su1835 – Vedolizumab Use is Not Associated with Increased Malignancy Incidence: Gemini Long-Term Safety Study Results and Post-Marketing Data

Card, Timothy, Ungaro, Ryan C., Bhayat, Fatima, Blake, Aimee, Hantsbarger, Gary, Travis, Simon P.

Journal:

Gastroenterology

Year:

2019

Language:

english

File:

PDF, 963 KB

english, 2019

15

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

Card, Timothy, Ungaro, Ryan, Bhayat, Fatima, Blake, Aimee, Hantsbarger, Gary, Travis, Simon

Journal:

Alimentary Pharmacology & Therapeutics

Year:

2019

Language:

english

File:

PDF, 566 KB

english, 2019